Thursday, April 30, 2026 11:35:01 AM
Sage, The answer to your question, “wouldn’t it be a simple exercise to tally up the shares versus the official outstanding shares and bring that to the SEC’s attention?” is two parts:
1. The actual vote numbers are hidden. NWBO is not able to see those “extra” naked shares voting and has no access, so it would not be able to tally and submit it to the SEC.
See “Side notes: trimming services” at bottom of this 4/28/26 post:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177549509
(In other words, the system treats “over-voting” as a processing error rather than evidence of potential criminal activity, ie a way to by-pass SEC laws, ie the FTD reporting clock.)
2. When retail buys through a brokerage, they are buying a legal claim to a mark-to-market financial asset. It is not a specific stock certificate number. They do sum up the number of shares, but it is substantially ownership of a dollar amount.
I explain this in a post to Gary on 4/25/26:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177539906
1. The actual vote numbers are hidden. NWBO is not able to see those “extra” naked shares voting and has no access, so it would not be able to tally and submit it to the SEC.
See “Side notes: trimming services” at bottom of this 4/28/26 post:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177549509
(In other words, the system treats “over-voting” as a processing error rather than evidence of potential criminal activity, ie a way to by-pass SEC laws, ie the FTD reporting clock.)
2. When retail buys through a brokerage, they are buying a legal claim to a mark-to-market financial asset. It is not a specific stock certificate number. They do sum up the number of shares, but it is substantially ownership of a dollar amount.
I explain this in a post to Gary on 4/25/26:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177539906
Sharing thoughts and opinions. To participate in group due diligence. Motto: Do not be a gullible FUDdable investor.
Recent NWBO News
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
